Centessa Pharmaceuticals Investor Relations Material
Latest events
Study Update
Centessa Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Centessa Pharmaceuticals plc
Access all reports
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company dedicated to discovering, developing, and delivering transformative medicines. Established in 2020, the company focuses on developing a wide range of innovative treatments across various therapeutic areas, including rare diseases and immuno-oncology. Centessa Pharmaceuticals is headquartered in Altrincham, United Kingdom, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CNTA
Country
🇺🇸 United States